New device screens for HIV among Mozambique infants

Organisation: Position: Deadline Date: Location:

[b]Alere Inc[/b] has announced a study demonstrating the viability of accurate and rapid HIV screening among 827 infants at the point of care (POC), reports [s]The Wall Street Journal[/s]. The study was conducted in five clinics in [b]Maputo, Mozambique[/b], with the prototype of Alere’s new POC nucleic acid test. Commenting on the study results, Dr Landon Myer of the [b]School of Public Health, University of Cape Town[/b], said: ‘The ability to provide a definitive HIV test result in less than 60 minutes changes how we relate to our patients and how patientsexperience the healthcare system. If approved, this test will allow us to immediately initiate ART in HIV-positive infants, and reduce morbidity and mortality in this vulnerable population.’

Full report in The Wall Street Journal
Journal of Acquired Immune Deficiency Syndromes abstract

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.